Nitrous oxide emissions are greater in silt loam soils with a legacy of manure application than without

Soil carbon (C) content, often found at elevated levels in manured soils, can play a critical role in regulating nitrous oxide emissions. Nitrate availability and oxygen status are the other primary drivers of emissions, yet the interaction of these three variables and the dynamics of the denitrification process are inadequately known. Emissions of N₂O and N₂ were measured from two New York State soils that were historically managed either with regular cattle manure applications (M) or without manure (NM). For 168 h, repacked soil cores were maintained at 80 % water-filled pore space after the application of 0, 50, 100, and 200 kg ha^?1 of labeled K¹⁵NO₃. Significant differences were found in the N₂O emission profiles between the two treatments with a simultaneous increasing trend in emissions with higher fertilizer applications. The M soil produced 53-, 15.5-, and 8.6-fold increases in N₂O emissions over the NM soil at the 50-, 100-, and 200-kg ha^?1 N rates, respectively. Additionally, the mean ratio of nitrous oxide to total denitrification (N₂O/(N₂O + N₂)) was higher for M soil. It increased to values of 0.17, 0.25, and 0.43 for fertilizer rates of 50, 100, and 200 kg ha^?1, respectively, in contrast to ratios in the NM soil of 0.01, 0.03, and 0.14.     

Arsenic mobility and groundwater extraction in Bangladesh

High levels of arsenic in well water are causing widespread poisoning in Bangladesh. In a typical aquifer in southern Bangladesh, chemical data imply that arsenic mobilization is associated with recent inflow of carbon. High concentrations of radiocarbon-young methane indicate that young carbon has driven recent biogeochemical processes, and irrigation pumping is sufficient to have drawn water to the depth where dissolved arsenic is at a maximum. The results of field injection of molasses, nitrate, and low-arsenic water show that organic carbon or its degradation products may quickly mobilize arsenic, oxidants may lower arsenic concentrations, and sorption of arsenic is limited by saturation of aquifer materials.     

Feline platelet counting with prostaglandin E1 on the Sysmex XT‐2000iV

Background: The large size of many feline platelets and the high frequency of platelet aggregation often results in falsely low platelet counts in this species. A combination of optical platelet counting to detect even large platelets and the use of prostaglandin E1 (PGE1) to inhibit platelet clumping may increase the accuracy of feline platelet counting. Objective: The objective of this study was to compare platelet counts in feline whole blood samples with and without the addition of PGE1 and using different analytical methods in a clinical setting. Methods: Platelet counts were determined in 10 feline patients in a referral veterinary hospital using 2 sample types (EDTA, EDTA with PGE1) and 2 methods of analysis (optical counting [PLT‐O] and impedance counting [PLT‐I]) on the Sysmex XT 2000 iV analyzer. Results: All PGE1–PLT‐O samples had platelet counts of >200 × 10⁹/L. Mean platelet count using PGE1–PLT‐O (410,256±178 × 10⁹/L) was significantly higher (P<.03) compared with PGE1–PLT‐I (256±113 × 10⁹/L), EDTA–PLT‐O (238±107 × 10⁹/L), and EDTA–PLT‐I (142±84 × 10⁹/L) methods. Depending on the method, platelet counts in 2 to 7 of 10 cats were <200 × 10⁹/L when PGE1‐PLT‐O was not used. A slightly increased platelet count in response to treatment of a feline patient with thrombocytopenia would have been missed without use of PGE1–PLT‐O. Conclusions: Using PLT‐O analysis on EDTA samples containing PGE1 provides higher, and therefore likely more accurate, feline platelet counts in a clinical setting.     

Concentrations of gentamicin in serum and bronchial lavage fluid after once-daily aerosol administration to horses for seven days

OBJECTIVE: To assess gentamicin concentrations in serum and bronchial lavage fluid (BLF) of horses during a 24-hour period after once-daily aerosol administration of gentamicin (GAER) for 7 days and the pattern and degree of bronchial tree inflammation associated with repeated GAER. ANIMALS: 13 healthy adult horses (9 geldings and 4 mares). PROCEDURE: The treatment group comprised 8 horses, and 5 horses were untreated control animals. Gentamicin (20 mL of gentamicin [50 mg/mL]) was administered via aerosol once daily for 7 days. Samples of serum and BLF were obtained from all horses before GAER and 0.5, 4, 8, and 24 hours after the final day of GAER. Gentamicin concentrations were determined for all samples from treated horses, and cytologic examinations were performed on all BLF samples. RESULTS: Peak median BLF gentamicin concentration detected at 0.5 hours was 2.50 microg/mL. Median serum gentamicin concentration was < 0.50 microg/mL at all time points. Significant differences were not observed in total nucleated cell counts or differential cell counts in BLF between groups at any time point. Neutrophil count in BLF for all horses was increased over baseline at 4 and 24 hours. CONCLUSIONS AND CLINICAL RELEVANCE: We did not detect evidence of gentamicin accumulation or respiratory inflammation after once-daily GAER for 7 days. This protocol appears unlikely to result in local or systemic toxicosis. Repeated daily GAER to horses appears to be a safe procedure and may have clinical use in the treatment of horses with bacterial infections of the airways.     

Economical preparation of fluids for intravenous use in cattle practice

The equipment and materials necessary to prepare and safely administer fluids intravenously to cattle are described. The preparation and clinical uses of Hartmann's solution are discussed, together with modifications of the solution to permit its application to different disease states.     

PATHOPHYSIOLOGICAL EFFECTS OF RENAL ALLOGRAFTS IN THE DOG

Seven dogs with renal allografts were studied to: (1) determine the practicality of the procedure for the treatment of end stage kidney disease in small animal medicine, and (2) measure allograft function to permit evaluation of immunosuppressive drug dosage to prevent rejection. Infection (bacterial nephritis, pneumonia, pleuritis), drug toxicity (bone marrow depression, liver degeneration and/or necrosis), and rejection of the transplants were the consistent problems. No objective measurement which would permit accurate determination of immunosuppressive drug dosage was found. Polyuria in the transplanted animals was attributed to failure to develop the interstitial osmotic gradient essential for the allografts to respond to antidiuretic hormone. Polydipsia probably was compensation for the polyuria. The results would indicate that until a major immunological breakthrough occurs in tissue transplantation, the clinical placement of a renal allograft in the dog for long term function is not practical. Prolonged function of the renal allograft has been accomplished in the dog using immunosuppressive drugs, suggesting that the procedure can be utilized for the treatment of end stage renal disease in this animal.¹⁸ Immunosuppressive drugs have inherent toxicities, of which bone marrow depression, liver and gastrointestinal tract damage are most notable.^5,18,23 Ideally, minimal immunosuppression is desired to avoid drug toxicity, maintain some degree of immune competence to reduce chances of serious, if not fatal infection, and yet allow the transplanted kidney to survive in a hostile immune environment.²² There are no good measurements to determine the immunological status of patients on immunosuppressive therapy,²² consequently, such treatment is emperic; based on experimental and clinical experience. ^13,18 Although the dog is a common model for renal allograft investigations, ^15,18 there is limited information in the veterinary literature 3.5.6,11,14 concerning the experience of veterinary clinicians and their attempts to maintain the renal homograft. This report summarizes the author's experiment with renal transplants in the dog.